Dog · Canis lupus familiaris · typical adult weight 2.00–80.00 kg
Budesonide Oral is dosed at 0.1–0.2 mg/kg PO q24h in dogs, per Dye TL, Diehl KJ, Wheeler SL, Westfall DS. Randomized, Controlled Trial of Budesonide and Prednisone for the Treatment of Idiopathic Inflammatory Bowel Disease in Dogs. Journal of Veterinary Internal Medicine. 2013;27(6):1385-1391. doi:10.1111/jvim.12195; Tumulty JW, Broussard JD, Steiner JM, Peterson ME, Williams DA. Clinical effects of short-term oral budesonide on the hypothalamic-pituitary-adrenal axis in dogs with inflammatory bowel disease. JAAHA. 2004;40(2):120-123. doi:10.5326/0400120 — Verified against Plumb's Veterinary Drug Handbook, 10th Ed, p.170 (2026-08-01).. Budesonide Oral is used in dogs for Inflammatory bowel disease (IBD). Routes documented in dogs: PO. A typical adult dog weighs 2.00–80.00 kg. ExoticRx lists 1 cited dose rule for Budesonide Oral in dogs, drawn from published veterinary references. Verify against current literature before clinical use.
US trade names: Entocort EC, Ortikos
| Route | Dose | Frequency | Duration | Indication | Evidence | Source |
|---|---|---|---|---|---|---|
| PO | 0.1–0.2 mg/kgmax 9 mg total | q24h | 4-8 weeks, then taper; may require long-term low dose | Inflammatory bowel disease (IBD) | Strong | Dye TL, Diehl KJ, Wheeler SL, Westfall DS. Randomized, Controlled Trial of Budesonide and Prednisone for the Treatment of Idiopathic Inflammatory Bowel Disease in Dogs. Journal of Veterinary Internal Medicine. 2013;27(6):1385-1391. doi:10.1111/jvim.12195; Tumulty JW, Broussard JD, Steiner JM, Peterson ME, Williams DA. Clinical effects of short-term oral budesonide on the hypothalamic-pituitary-adrenal axis in dogs with inflammatory bowel disease. JAAHA. 2004;40(2):120-123. doi:10.5326/0400120 — Verified against Plumb's Veterinary Drug Handbook, 10th Ed, p.170 (2026-08-01). |
Need the exact dose for your patient?
These ranges are per kg. Enter your dog's weight to get the precise dose and draw-up volume — unit and concentration math done for you.
Potent glucocorticoid with high first-pass hepatic metabolism, providing topical anti-inflammatory effect on GI mucosa with reduced systemic bioavailability.
Fewer systemic corticosteroid effects than prednisone but not zero. Used for IBD in dogs and cats. Monitor for adrenal suppression with prolonged use.
Species-specific contraindications and adverse-reaction reports for dogs may differ from canine / feline reference data — consult the primary citations listed with each rule.
Budesonide Oral dose range in dogs, with cited source references: PO 0.1–0.2 mg/kg q24h. Reference ranges from cited sources — verify against current literature before clinical use.
Documented routes for Budesonide Oral in dogs: PO.
Cited course lengths for Budesonide Oral in dogs include: 4-8 weeks, then taper; may require long-term low dose. Duration depends on the indication — match it to the specific dose rule in the table above.
Budesonide Oral is indicated in dogs for: Inflammatory bowel disease (IBD).
These are general warnings for Budesonide Oral across species; consult the dog dosing table above for species-specific guidance. Fewer systemic corticosteroid effects than prednisone but not zero. Used for IBD in dogs and cats. Monitor for adrenal suppression with prolonged use.
Why a species-specific page? Budesonide Oral pharmacokinetics differ across species: dose ranges, intervals, and route preferences are not interchangeable. Cross-extrapolation from canine doses is unsafe in dogs — the rules above are the citations specific to this species, not generic recommendations.
Sourced from published veterinary references; awaiting credentialed clinical reviewer. See our editorial process. Reference only — not veterinary advice.